106 related articles for article (PubMed ID: 6545124)
1. Opiate abstinence head-shaking model in infant rats.
Pérez-Saad H; Figueredo P; Urba-Holmgren R
Bol Estud Med Biol; 1984-1985; 33(1-8):13-24. PubMed ID: 6545124
[No Abstract] [Full Text] [Related]
2. Injections of an opioid antagonist into the locus coeruleus and periaqueductal gray but not the amygdala precipitates morphine withdrawal in the 7-day-old rat.
Jones KL; Barr GA
Synapse; 2001 Feb; 39(2):139-51. PubMed ID: 11180501
[TBL] [Abstract][Full Text] [Related]
3. Nuclear factor-kappa-B inhibitor modulates the development of opioid dependence in a mouse model of naloxone-induced opioid withdrawal syndrome.
Rehni AK; Bhateja P; Singh TG; Singh N
Behav Pharmacol; 2008 May; 19(3):265-9. PubMed ID: 18469544
[TBL] [Abstract][Full Text] [Related]
4. Ventral pallidal injections of a mu antagonist block the development of behavioral sensitization to systemic morphine.
Johnson PI; Napier TC
Synapse; 2000 Oct; 38(1):61-70. PubMed ID: 10941141
[TBL] [Abstract][Full Text] [Related]
5. Gender- and morphine dose-linked expression of spontaneous somatic opiate withdrawal in mice.
Papaleo F; Contarino A
Behav Brain Res; 2006 Jun; 170(1):110-8. PubMed ID: 16580078
[TBL] [Abstract][Full Text] [Related]
6. Lack of neuropeptide Y attenuates the somatic signs of opiate withdrawal.
Olson VG; Griner NB; Heusner CL; Palmiter RD
Synapse; 2006 Dec; 60(7):553-6. PubMed ID: 16952158
[TBL] [Abstract][Full Text] [Related]
7. Analgesic activity and pharmacological characterization of N-[1-phenylpyrazol-3-yl]-N-[1-(2-phenethyl)-4-piperidyl] propenamide, a new opioid agonist acting peripherally.
Goicoechea C; Sánchez E; Cano C; Jagerovic N; Martín MI
Eur J Pharmacol; 2008 Oct; 595(1-3):22-9. PubMed ID: 18706410
[TBL] [Abstract][Full Text] [Related]
8. [Problems in quantification of provoked morphine withdrawal in rats].
Herz A; Bläsig J
Arzneimittelforschung; 1974 Jul; 24(7):1012-4. PubMed ID: 4408092
[No Abstract] [Full Text] [Related]
9. Cocaine attenuates opiate withdrawal in human and rat.
Kosten TA
NIDA Res Monogr; 1989; 95():361-2. PubMed ID: 2640996
[No Abstract] [Full Text] [Related]
10. [Hypothalamic self-stimulation during the abstinence syndrome in morphine-dependent rats].
Zvartau EE
Biull Eksp Biol Med; 1978 Mar; 85(3):304-7. PubMed ID: 566590
[TBL] [Abstract][Full Text] [Related]
11. Plasma malondialdehyde levels and opiate withdrawal signs observed in rats treated with morphine plus naloxone: effects of alpha-lipoic acid administration.
Pinelli A; Cighetti G; Trivulzio S
Fundam Clin Pharmacol; 2008 Aug; 22(4):439-45. PubMed ID: 18705754
[TBL] [Abstract][Full Text] [Related]
12. Agonist and antagonist effects of prototype opiate drugs in rats discriminating fentanyl from saline: characteristics of partial generalization.
Colpaert FC; Janssen PA
J Pharmacol Exp Ther; 1984 Jul; 230(1):193-9. PubMed ID: 6747824
[TBL] [Abstract][Full Text] [Related]
13. Severe deficit in brain reward function associated with fentanyl withdrawal in rats.
Bruijnzeel AW; Lewis B; Bajpai LK; Morey TE; Dennis DM; Gold M
Biol Psychiatry; 2006 Mar; 59(5):477-80. PubMed ID: 16169528
[TBL] [Abstract][Full Text] [Related]
14. Studies on the abstinence-like overshoot following reversal of the potent 19-isoamyl derivative of etorphine with naloxone. A comparison with the opioids fentanyl and alfentanil.
Freye E; Neruda B; Smith OW
Arzneimittelforschung; 1997 Jan; 47(1):6-9. PubMed ID: 9037435
[TBL] [Abstract][Full Text] [Related]
15. Acute opioid physical dependence in humans: naloxone dose response effects.
Heishman S; Stitzer M
NIDA Res Monogr; 1988; 81():195-201. PubMed ID: 3136361
[No Abstract] [Full Text] [Related]
16. Neuropeptide Y attenuates naloxone-precipitated morphine withdrawal via Y5-like receptors.
Woldbye DP; Klemp K; Madsen TM
J Pharmacol Exp Ther; 1998 Feb; 284(2):633-6. PubMed ID: 9454808
[TBL] [Abstract][Full Text] [Related]
17. Opioid tolerance and dependence in light of the multiplicity of opioid receptors.
Schulz R; Herz A
NIDA Res Monogr; 1984; 54():70-80. PubMed ID: 6099881
[No Abstract] [Full Text] [Related]
18. Relative sensitivity to naloxone of multiple indices of opiate withdrawal: a quantitative dose-response analysis.
Schulteis G; Markou A; Gold LH; Stinus L; Koob GF
J Pharmacol Exp Ther; 1994 Dec; 271(3):1391-8. PubMed ID: 7996451
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological analysis of acute morphine dependence in infant rats: close molecular relationship of head-shaking precipitated by opiate antagonists and cholinergic neurotransmission.
Pérez-Saad H; Urba-Holmgren R; Holmgren B
Arch Med Res; 1996; 27(2):139-44. PubMed ID: 8696055
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of ganglionic transmission by narcotic analgesics; an effect antagonized by naloxone, nalorphine and calcium.
Minker E; Végh A; Blazsó G
Acta Physiol Acad Sci Hung; 1981; 58(2):157-62. PubMed ID: 6122334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
